Former DBS CEO is Temasek India's new non-exec chair
Mumbai, Nov. 29 -- Piyush Gupta, the former chief executive of DBS Group, has joined Singaporean state-owned multinational investment firm Temasek as India chairman, albeit in a non-executive role, and will work with Ravi Lambah, head of India and strategic initiatives, the firm said. He will join on 1 December.
Temasek added that Gupta will also work closely with the India team on their investment strategies, partner and support Temasek portfolio companies as they identify opportunities in India. He will also engage with the government and business communities, it added.
"Piyush brings extensive business insights and strong connections developed over decades in financial services," said Dilhan Pillay, executive director and CEO, Temasek Holdings. "Complementing Ravi's leadership of our India market, he will offer strategic counsel and strengthen our institutional networks in India and beyond, enhance franchise value, and expand our portfolio access," he added.
As the chief executive officer of the DBS Group from 2009 to 2025, Gupta led its widely recognised digital transformation and regional expansion.
Before joining DBS, he had a 27-year stint in Citigroup as CEO for Southeast Asia, Australia and New Zealand.
Gupta is currently the deputy chairman of global asset manager Keppel, chairman of the board of trustees of Singapore Management University, and chairman of board at Mandai Park Holdings. He holds various senior advisory roles in Singapore and around the world as well, Temasek added.
"I am honoured with this opportunity to work with the Temasek India team. Having been engaged with the Temasek ecosystem for many years, I look forward to collaborating with the team to deepen partnerships, pursue new opportunities, and contribute to Temasek's continued growth in India," he said.
Temasek is a global investment company headquartered in Singapore with a net portfolio value of close to $324 billion as of 31 March. In 2024, it invested more than $1 billion for a 10% stake in Agarwal family-backed Haldiram Food International Pvt. Ltd, and around $2 billion for a majority control of Pai-family-operated Manipal Health Enterprises. Temasek's India portfolio soared to $50 billion as of July 2025 from $37 billion as of July 2024, Mint reported at the time....
To read the full article or to get the complete feed from this publication, please
Contact Us.